Scarica l'app Stockscreener
8.02
2.30%
0.18
Precedente Chiudi:
$7.84
Aprire:
$7.9
Volume 24 ore:
1.22M
Relative Volume:
0.77
Capitalizzazione di mercato:
$697.88M
Reddito:
-
Utile/perdita netta:
$-168.09M
Rapporto P/E:
-3.6959
EPS:
-2.17
Flusso di cassa netto:
$-138.01M
1 W Prestazione:
+8.38%
1M Prestazione:
-12.54%
6M Prestazione:
+29.35%
1 anno Prestazione:
-3.95%
Intervallo 1D:
$7.625
$8.045
Intervallo di 1 settimana:
$7.50
$8.08
Portata 52W:
$5.41
$12.49
Kura Oncology Inc Stock (KURA) Company Profile
Nome
Kura Oncology Inc
Settore
Industria
Telefono
(858) 500-8800
Indirizzo
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA
Compare KURA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
8.02 | 682.22M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | Guggenheim | Neutral |
| 2025-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-14 | Downgrade | Stifel | Buy → Hold |
| 2023-12-22 | Iniziato | Mizuho | Buy |
| 2023-08-11 | Iniziato | BofA Securities | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Perform |
| 2023-05-17 | Iniziato | BTIG Research | Buy |
| 2023-01-31 | Iniziato | Stifel | Buy |
| 2022-07-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-02-15 | Iniziato | Jefferies | Buy |
| 2021-05-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-11-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Iniziato | Credit Suisse | Outperform |
| 2020-05-05 | Iniziato | Barclays | Overweight |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2018-11-09 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-01 | Iniziato | H.C. Wainwright | Buy |
| 2016-10-13 | Ripresa | Leerink Partners | Outperform |
| 2016-01-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-30 | Iniziato | Oppenheimer | Outperform |
| 2015-12-16 | Iniziato | Citigroup | Buy |
Mostra tutto
Kura Oncology Inc Borsa (KURA) Ultime notizie
IPO Launch: Is Kura Oncology Inc a strong candidate for buy and holdJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
Is Kura Oncology Inc. vulnerable to short sellersPortfolio Return Report & Daily Price Action Insights - mfd.ru
The Truth About Kura Oncology Inc: Is This Sleeper Cancer Stock About To Explode? - AD HOC NEWS
Kura Oncology (KURA) Issues Stock Options to New Employees - GuruFocus
Kura Oncology Grants Inducement Stock Options to New Employees as Part of 2023 Inducement Option Plan - Quiver Quantitative
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Need To Know: The Consensus Just Cut Its Kura Oncology, Inc. (NASDAQ:KURA) Estimates For 2026 - simplywall.st
Why (KURA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Analyst flags Kura Oncology, Inc. (KURA) for 2026 milestones and pipeline expansion - MSN
Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion - Yahoo Finance
Citizens reiterates Market Outperform rating on Kura Oncology stock By Investing.com - Investing.com Canada
ETF Watch: Is AVDL vulnerable to short sellers2025 Top Decliners & High Accuracy Investment Entry Signals - baoquankhu1.vn
Treasury Yields: Whats the profit margin of Kura Oncology IncWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Nan Fung Trinity HK Ltd. Invests $2.04 Million in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. (KURA) Growth Potential: Analyst Ratings Suggest A 295.93% Upside - DirectorsTalk Interviews
Kura Oncology Tightens Governance with Amended Bylaws - TipRanks
Don't Ignore The Insider Selling In Kura Oncology - simplywall.st
Insider Selling: Kura Oncology (NASDAQ:KURA) Insider Sells 6,414 Shares of Stock - MarketBeat
Why is Kura Oncology Inc. stock going upWeekly Risk Report & Low Drawdown Trading Techniques - mfd.ru
Kura Oncology’s chief medical officer, Leoni, sells $69k in stock - Investing.com Australia
Kura oncology CSO Burrows sells $11k in shares By Investing.com - Investing.com Australia
Kura Oncology COO Ford sells $15,339 in stock By Investing.com - Investing.com UK
Kura Oncology’s chief legal officer sells $94,827 in stock By Investing.com - Investing.com UK
Kura Oncology’s chief legal officer sells $94,827 in stock - Investing.com
Kura Oncology (NASDAQ:KURA) Insider Mollie Leoni Sells 8,180 Shares - MarketBeat
Kathleen Ford Sells 1,813 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Oncology (NASDAQ:KURA) Insider Sells $11,091.06 in Stock - MarketBeat
Insider Selling: Kura Oncology (NASDAQ:KURA) SVP Sells 7,142 Shares of Stock - MarketBeat
Teresa Brophy Bair Sells 11,208 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Oncology’s chief medical officer, Leoni, sells $69k in stock By Investing.com - Investing.com South Africa
Kura Oncology SVP sells $60k in shares By Investing.com - Investing.com Nigeria
Kura Oncology CCO Powl sells $54,266 in stock By Investing.com - Investing.com Australia
Kura oncology CSO Burrows sells $11k in shares - Investing.com
Kura Oncology SVP sells $60k in shares - Investing.com
Kura Oncology CCO Powl sells $54,266 in stock - Investing.com
Kura Oncology COO Ford sells $15,339 in stock - Investing.com
Understanding Momentum Shifts in (KURA) - Stock Traders Daily
Sector Gamma AS Takes $3.88 Million Position in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. (KURA) Rating Update: 258% Potential Upside Highlights Growth Potential In Biotech Sector - DirectorsTalk Interviews
Kura Oncology (NASDAQ:KURA) Cut to "Strong Sell" at Zacks Research - MarketBeat
Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy (NASDAQ:KURA) - Seeking Alpha
Kura Oncology (NASDAQ:KURA) Nasdaq 100 Index Clinical Research Focus - Kalkine Media
Jim Cramer calls Kura speculative but says "It's one of the stronger ones I've seen in a very long time" - MSN
Does Kura Oncology (NASDAQ:KURA) Have A Healthy Balance Sheet? - 富途资讯
Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 37.5% in December - MarketBeat
Kura Oncology's finance SVP sells shares worth $38,958 - MSN
Kura Oncology price target lowered to $20 from $25 at Leerink - Yahoo Finance
FY2025 EPS Forecast for Kura Oncology Reduced by Analyst - MarketBeat
Kura Oncology Inc Azioni (KURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):